Outset Medical (OM) Receivables (2019 - 2026)

Outset Medical (OM) has 8 years of Receivables data on file, last reported at $25.3 million in Q1 2026.

• On a quarterly basis, Receivables fell 31.36% year-over-year to $25.3 million in Q1 2026; TTM through Mar 2026 was $25.3 million, a 31.36% decrease from a year earlier, with the FY2025 full-year figure at $28.3 million, down 20.47% from the prior year.
• Receivables for Q1 2026 stood at $25.3 million, down from $28.3 million in the prior quarter.
• Over the last five years, Receivables for OM reached as high as $36.9 million in Q2 2023 and fell as low as $22.5 million in Q3 2022.
• Historically, Receivables has averaged $31.8 million across 5 years, with a median of $34.1 million in 2024.
• Across the five-year window, Receivables surged 122.12% in 2022 and sank 31.36% in 2026, its largest moves.
• Year by year, Receivables stood at $28.1 million in 2022, then advanced by 17.49% to $33.0 million in 2023, then grew by 8.0% to $35.6 million in 2024, then retreated by 20.47% to $28.3 million in 2025, then declined by 10.61% to $25.3 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $25.3 million in Q1 2026, $28.3 million in Q4 2025, and $33.0 million in Q3 2025.